332 related articles for article (PubMed ID: 16275762)
1. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
4. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length.
Green KJ; Miles JJ; Tellam J; van Zuylen WJ; Connolly G; Burrows SR
Eur J Immunol; 2004 Sep; 34(9):2510-9. PubMed ID: 15307183
[TBL] [Abstract][Full Text] [Related]
5. CTL recognition of a bulged viral peptide involves biased TCR selection.
Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
[TBL] [Abstract][Full Text] [Related]
6. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope.
Miles JJ; Borg NA; Brennan RM; Tynan FE; Kjer-Nielsen L; Silins SL; Bell MJ; Burrows JM; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2006 Nov; 177(10):6804-14. PubMed ID: 17082594
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of suboptimal viral fragments of Epstein Barr Virus Rta peptide-HLA complex that stimulate CD8 T cell response.
Huan X; Zhuo Z; Xiao Z; Ren EC
Sci Rep; 2019 Nov; 9(1):16660. PubMed ID: 31723204
[TBL] [Abstract][Full Text] [Related]
8. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
[TBL] [Abstract][Full Text] [Related]
9. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
[TBL] [Abstract][Full Text] [Related]
10. Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses.
Bihl F; Frahm N; Di Giammarino L; Sidney J; John M; Yusim K; Woodberry T; Sango K; Hewitt HS; Henry L; Linde CH; Chisholm JV; Zaman TM; Pae E; Mallal S; Walker BD; Sette A; Korber BT; Heckerman D; Brander C
J Immunol; 2006 Apr; 176(7):4094-101. PubMed ID: 16547245
[TBL] [Abstract][Full Text] [Related]
11. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
Turcanová V; Höllsberg P
J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
[TBL] [Abstract][Full Text] [Related]
12. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
13. Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes.
Pepperl S; Benninger-Döring G; Modrow S; Wolf H; Jilg W
J Virol; 1998 Nov; 72(11):8644-9. PubMed ID: 9765404
[TBL] [Abstract][Full Text] [Related]
14. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
[TBL] [Abstract][Full Text] [Related]
15. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
Benninger-Döring G; Pepperl S; Deml L; Modrow S; Wolf H; Jilg W
Virology; 1999 Nov; 264(2):289-97. PubMed ID: 10562493
[TBL] [Abstract][Full Text] [Related]
16. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection.
Elliott SL; Pye SJ; Schmidt C; Cross SM; Silins SL; Misko IS
J Infect Dis; 1997 Oct; 176(4):1068-72. PubMed ID: 9333169
[TBL] [Abstract][Full Text] [Related]
17. CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection.
Kamga L; Gil A; Song I; Brody R; Ghersi D; Aslan N; Stern LJ; Selin LK; Luzuriaga K
PLoS Pathog; 2019 Nov; 15(11):e1008122. PubMed ID: 31765434
[TBL] [Abstract][Full Text] [Related]
18. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus.
Bogedain C; Wolf H; Modrow S; Stuber G; Jilg W
J Virol; 1995 Aug; 69(8):4872-9. PubMed ID: 7609055
[TBL] [Abstract][Full Text] [Related]
19. Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines.
Crotzer VL; Christian RE; Brooks JM; Shabanowitz J; Settlage RE; Marto JA; White FM; Rickinson AB; Hunt DF; Engelhard VH
J Immunol; 2000 Jun; 164(12):6120-9. PubMed ID: 10843661
[TBL] [Abstract][Full Text] [Related]
20. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
